InvestorsHub Logo
Followers 145
Posts 27558
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Wednesday, 10/05/2016 11:47:59 AM

Wednesday, October 05, 2016 11:47:59 AM

Post# of 2026
NASH event today to inform investors

Oct 5 2016, 11:21 ET | By: Douglas W. House, SA News Editor Contact this editor with comments or a news tip

Slingshot Insights is hosting an exert interview today at 2:00 pm ET focused on non-alcoholic steatohepatitis (NASH), a sizable market opportunity for drug makers that many call the "next hepatitis C." The space has heated up recently stoked by Allergan's (NYSE:AGN) $1.7B takeout of Tobira Therapeutics (NASDAQ:TBRA) and $50M acquisition of privately held Akarna Therapeutics.SA subscribers should use their 90-day coupon code SA_Sub16.NASH-related tickers: (NYSE:PFE)(NASDAQ:GALT)(NASDAQ:BLRX)(NASDAQ:GLMD)(NASDAQ:CNAT)(NASDAQ:MNOV)(NASDAQ:RGLS)(NASDAQ:ICPT)(NASDAQ:SHPG)(NYSEMKT:CANF)(NASDAQ:VBLT)(OTCPK:ISLT)(OTCPK:GNFTF)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News